Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation is a research paper published in Genetics in Medicine (2022). On theSindex it has a DataRank of 0.846. It has been cited 281 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.846
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute for Health Research (NIHR)
Grant: RP-2016-07-011
National Institutes of Health
Grant: 5R01CA201130-04
Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma
FWCI
27.66
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis
Additional file 1 of Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis
Additional file 2 of Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis
Additional file 2 of Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis
Additional file 3 of Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis
Additional file 3 of Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis